
Didn't make it to the AACE 2025 Clinical Guidance Forum? Explore the newest AACE clinical guidance documents presented by the experts who created them and earn up to 5 CME/CE/MOC credits. This on-demand resource offers practical, case-based learning to help you implement evidence-based care in obesity, dyslipidemia, multiple endocrine neoplasia type 1, and menopause management.
Program Highlights
- Stay at the cutting edge of endocrinology and join the premier virtual event on AACE Clinical Guidance delivering the latest guidelines, evidence-based standards, and emerging innovations.
- Hear from the authors of newly published AACE clinical guidance documents, and engage in expert-led discussions, case-based learning, and interactive sessions.
- Walk away with practical strategies to improve outcomes, tackle complex cases, and apply the newest advancements in your daily practice.

SCHEDULE
AT A GLANCE
AACE Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease – 2025 Update
Speakers:
- Timothy Garvey, MD, MACE
- Monica Agarwal, MD, FACE, MEHP, DABOM
- Marcio Griebeler, MD
AACE Consensus Statement on Management of Multiple Endocrine Neoplasia, Type 1
Speakers:
- Sina Jasim, MD, MPH
- Jaydira Del Rivero, MD
- Alexandra Gangi, MD
Transforming Patient Care with the Obesity Algorithm: Practical Insights
(This CME activity is supported by an independent educational grant from Novo Nordisk.)
Speakers:
- Dimpi Desai, MD
- Priya Jaisinghani, MD, ABOM
- Moderator: Jaime Almandoz, MD, MBA, DABOM, FTOS
AACE Clinical Practice Guideline on Pharmacologic Management of Adults with Dyslipidemia
Speakers:
- Kathleen Wyne, MD, PhD, FNLA, FACE
- Samina Afreen, MBBS
- Shahnaz Sultan, MD, MHSc
AACE Consensus Statement: Algorithm for Management of Adults with Dyslipidemia – 2025 Update
Speakers:
- Shailendra Patel, BM, CHB, PhD
- Maria Belalcazar, MD, FACE
- Aman Rajpal, MD, DABOM
Advances in Managing Menopause - Perimenopause and How Early to Start HRT
Speaker:
- Margaret Wierman, MD
PRICING
On-Demand Content + 5 CME/CE/MOC Credit
Includes virtual engaging panel discussions with the authors of:
- Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia
- Consensus Statement on Management of Multiple Endocrine Neoplasia Type 1
- AACE Consensus Statement: Algorithm for Management of Adults with Dyslipidemia – 2025 Update
- AACE Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease – 2025 Update
Program is eligible for 5 CME/CE/MOC Credit
Nonmember Pricing: $165 | Informed Member - $125 | Engaged Member - $99 | Fellow/Student $49 (AACE Membership Required)

Learning Objectives
At the end of this activity, participants will be able to:
- Evaluate recent updates in clinical guidelines for the management of common endocrine disorders and integrate these recommendations into everyday practice to optimize patient care.
- Implement strategies to enhance patient engagement, adherence, and clinical outcomes through effective communication and education, with a focus on recognizing and addressing health disparities in diverse and underserved populations.
- Examine emerging innovations in subspecialty areas of endocrinology and collaborate within multidisciplinary care teams to manage complex endocrine conditions more effectively.
CONTINUING MEDICAL
EDUCATION INFORMATION
Clinical Guidance Forum
Event start date: 12/10/2025
Credit claim deadline: 12/31/2025
Statement of Need
Clinicians managing endocrine disorders must remain up to date on evolving guidelines, innovations, and best practices to provide optimal care. Education is needed to strengthen communication, address health disparities, and support effective multidisciplinary collaboration that improves patient outcomes.
Target Audience
AACE Community (members and nonmembers) who have a need/interest to greater understand AACE’s clinical guidelines and how they can enhance their role in patient care – Endocrinologists, PCPs, NPs, PAs, Diabetes educators.
Learning Objectives
By the end of this conference, participants will be able to:
- Evaluate recent updates in clinical guidelines for the management of common endocrine disorders and integrate these recommendations into everyday practice to optimize patient care.
- Implement strategies to enhance patient engagement, adherence, and clinical outcomes through effective communication and education, with a focus on recognizing and addressing health disparities in diverse and underserved populations.
- Examine emerging innovations in subspecialty areas of endocrinology and collaborate within multidisciplinary care teams to manage complex endocrine conditions more effectively.
Accreditation and Designation Statements
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Endocrinology (ACE) designates this other (live virtual) activity for a maximum of 5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit. Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.
Disclosure and Conflicts of Interest Policy
The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.
Planning Committee Disclosures
Planner Name
Ricardo Correa, MD, EdD, FACP, FACE, FACMQ
Ineligible Company
Academy of Physician for Clinical Research
Maricopa County Medical Society
Arizona Medical Association
CECP ACP Governing Council
AMA IMG Governing Council
Moderna
Relevant Financial Relationship
Consultant
Consultant
Consultant
Consultant
Consultant
Vaccines Study
Planner Name
Joanna Miragaya, MD, PhD, FACE
Ineligible Company
None
Relevant Financial Relationship
None
All of the relevant financial relationships listed for these individuals have been mitigated. All other planners for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Faculty Disclosures
View our faculty disclosures.
View Faculty Disclosures
Reviewers
None of the reviewers for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
2025 PROGRAM
LEADERS

Chair
Ricardo Correa, MD, EdD, FACP, FACE, FACMQ

Vice Chair
Joanna Miragaya, MD, PhD, FACE